top of page

Meet the Team

Our mission-driven team is united by a shared sense of purpose and urgency: to bring a life-changing treatment to CMT1A patients as quickly as possible.

Ari on my shoulders
David Apple | Founder & CEO

Dedication. 

- My 5 yr old son Ari has CMT1A.

- Ari had an earlier onset and has a severe presentation.

- CMT1A is progressive, and is reported to get worse during puberty.

- I have a sense of urgency and will not stop until a treatment is available for Ari.

 

Track-record.  

- I'm a Mech Eng (Johns Hopkins) and an MBA (Imperial College London).

- I was the first go-to-market leader at Notion ($10B) and Typeform ($1B). 

- I advise Sequoia Capital, First Round Capital, and Headline Ventures.

- 3x Founder. Teleconnect (acquired), Apple Sustainability (ran profitably 5 yrs).

 

Perspective.

- I'm energized by solving hard problems. 

- I'm working backwards from the unmet need.

- I'm a Board Member of the CMT Association.

Leadership Team

Jordan VerPlank.jpeg

Jordan VerPlank, PhD

Chief Scientific Officer (Fractional)

Academic Research Scientist

CMT1A Expert

Wil Chow.jpeg

Wil Chow

Chief Technology Officer (Fractional)

Program Director in 10 Biotechs

7 IND molecules + 2 NDA drugs

Our Scientific Advisors.

Artie Suckow.jpeg

Artie Suckow, PhD

Former CEO of DTX Pharma

Board of CMTRF

Svaren-John-2022-400x400-1-300x300.jpg

John Svaren, PhD

U. Wisconsin | Chair CMTA SAB

Co-author Ionis CMT1A paper

Kim Popovits.jpeg

Kim Popovits

CEO Genomic Health

Prev. SVP at Genentech

Tom Dubensky.jpeg

Tom Dubensky, PhD

CEO ImmuneSensor

Board of CMTA

Tim Yu.jpeg

Tim Yu, MD, PhD

Professor Genetics & Genomics

Harvard Medical School

Davy Chiodin.jpeg

Davy Chiodin

Chief Development Officer

Day One Bio

Venkat Reddy.jpeg

Venkat Reddy

CSO at General Inception

CEO at Enable Medicine

Phil Reilly.jpeg

Phillip Reilly, MD

Co-Founder Luna Genetics

Co-Founder BlueBird Bio

Gregory Reaman.jpeg

Gregory Reaman, PhD

Prev. FDA Associate Director

Pediatric Oncology

Charlotte Sumner.jpeg

Charlotte Sumner, PhD

Professor of Neuroscience

Johns Hopkins Medical School

Haig Aghajanian.jpeg

Haig Aghajanian, PhD

Co-Founder Capstan Tx

Adj. Prof. U. Pennsylvania

Toby Ferguson.jpeg

Toby Ferguson, MD, PhD

Chief Medical Officer

Voyager Therapeutics

Steven Scherer.jpeg

Steve Scherer, MD, PhD

Professor of Neurology

University of Pennsylvania

Neil Kumar.webp

Neil Kumar, PhD

Founder & CEO

BridgeBio

Salim Dhanji.jpeg

Salim Dhanji, PhD

Co-Founder & CEO

ME Therapeutics

Sylvain Gariel.jpeg

Sylvain Gariel

Co-Founder & COO

DNA Script

Symbol + Wordmark - Dark - Square.png

Developing treatments for CMT1A, and unlocking solutions for other neuropathies.​

Follow Us:

  • LinkedIn
  • Twitter

© 2024 by Shark Tooth Biotech. All rights reserved.

bottom of page